Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa
NCT04979520
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Hidradenitis Suppurativa
Acne Inversa
Interventions
DRUG:
Brodalumab
Sponsor
Rockefeller University